Skip to content

CapEx at other companies

Eli Lilly logo
Eli LillyLLY
$2.33B+54.0%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$3.85M
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$35K-64.6%
LQD
Liquidia CorporationLQDA
$2.83M+758%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$69K
Opko Health logo
Opko HealthOPK
$1.83M-42.6%

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s capex?
Gyre Therapeutics, Inc. (GYRE) reported capex of $178K in Q1 2026.
How has Gyre Therapeutics, Inc.'s capex changed year-over-year?
Gyre Therapeutics, Inc.'s capex increased by 45.9% year-over-year, from $122K to $178K.
What is the long-term trend for Gyre Therapeutics, Inc.'s capex?
Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s capex has grown at a -38.0% compound annual growth rate (CAGR), from $4.99M to $1.19M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.